Episode Details
Back to Episodes
Episode 112: Moderna's scant coronavirus data and the plight of the day trader
Published 6 years, 5 months ago
Description
When is a press release worth $5 billion? Can biotech stocks replace sports? And how will we know if a coronavirus vaccine actually works?